Literature DB >> 32250649

Reply to Topeli et al. and to Akinosoglou et al.

Luciano C P Azevedo1, Alexandre B Cavalcanti1, Flavia R Machado1.   

Abstract

Entities:  

Year:  2020        PMID: 32250649      PMCID: PMC7328319          DOI: 10.1164/rccm.202003-0628LE

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


× No keyword cloud information.
From the Authors: We would like to thank Topeli and colleagues and Akinosoglou and colleagues for their interest in our manuscript (1). We carefully read the discussion by Topeli and colleagues on our data and their own results regarding quick sepsis-related organ dysfunction (qSOFA) and other scores for sepsismortality prediction in Turkey. We congratulate the authors for their initiative, as we believe it is very important to have data from low- and middle-income countries (LMICs). These countries represent more than 80% of world population, and the data from these settings on sepsis epidemiology and mortality are scarce (2). There are important similarities between the authors’ results and ours. They found that qSOFA score has the worst sensitivity to predict mortality in septic patients, which adds to previous LMICs’ studies showing that qSOFA has low sensitivity to predict sepsis mortality in this population (3, 4). However, there are also major differences comparing both results. Their study is a single-center retrospective cohort with a limited number of patients, as can be suggested by the large confidence intervals of the data. Additionally, they collected qSOFA variables from patients at 48 hours before ICU admission, whereas we collected qSOFA data considering only the worst values prior to the suspicion of infection or sepsis, which may have contributed to more accurate findings in our study. The time window is crucial in assessing the sensitivity of a screening tool, as it is expected that if the interval of data collection is increased, more patients that deteriorate and eventually die will have a qSOFA ≥2. It would also be important to evaluate in Topeli’s data whether the use of a single qSOFA variable would increase the sensitivity of the score, as we demonstrated in our study. This modified score could be suggested as an alternative to improve its accuracy in determining mortality in LMICs. Akinosoglou and colleagues assessed the role of qSOFA according to site of infection in a cohort of 614 septic patients from their institution. They identified that qSOFA accuracy to predict survival is dependent on the focus of infection. Because mortality rates are variable with the site of sepsis, and qSOFA variables may also be affected by the disease itself, their data are very reasonable. It would be interesting to assess data from other series to confirm if qSOFA can have adequate performance in all sepsis sites, or if we should modify the score according to the probable site of infection.
  4 in total

1.  Sepsis: A Threat That Needs a Global Solution.

Authors:  Flavia Ribeiro Machado; Luciano Cesar Pontes Azevedo
Journal:  Crit Care Med       Date:  2018-03       Impact factor: 7.598

2.  Predictive Accuracy of the Quick Sepsis-related Organ Failure Assessment Score in Brazil. A Prospective Multicenter Study.

Authors:  Flavia R Machado; Alexandre B Cavalcanti; Mariana B Monteiro; Juliana L Sousa; Aline Bossa; Antonio T Bafi; Felipe Dal-Pizzol; Flavio G R Freitas; Thiago Lisboa; Glauco A Westphal; Andre M Japiassu; Luciano C P Azevedo
Journal:  Am J Respir Crit Care Med       Date:  2020-04-01       Impact factor: 21.405

3.  Use of CRB-65 and quick Sepsis-related Organ Failure Assessment to predict site of care and mortality in pneumonia patients in the emergency department: a retrospective study.

Authors:  Yun-Xia Chen; Jun-Yu Wang; Shu-Bin Guo
Journal:  Crit Care       Date:  2016-06-01       Impact factor: 9.097

4.  Prognostic value of quickSOFA as a predictor of 28-day mortality among febrile adult patients presenting to emergency departments in Dar es Salaam, Tanzania.

Authors:  Noémie Boillat-Blanco; Zainab Mbarack; Josephine Samaka; Tarsis Mlaganile; Aline Mamin; Blaise Genton; Laurent Kaiser; Thierry Calandra; Valérie D'Acremont
Journal:  PLoS One       Date:  2018-06-14       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.